Sponsors (2)
The bill enforces federal funding restrictions to align grant eligibility with criminal law—protecting funding for compliant entities and legal consistency—but risks reducing harm‑reduction services (especially for Tribal and vulnerable communities), pushing programs underground, and shifting enforcement costs onto state and local governments.
State, local, Tribal, and private entities that do not operate supervised (unlawful) injection sites keep eligibility for federal grants, preserving funding for other public services and programs.
Aligns federal grant eligibility with existing federal criminal law to create a single legal standard for drug-related facilities, reducing federal-state legal conflicts over funding decisions.
Operators of supervised injection sites — including local programs and Tribal providers — could lose federal grants, contracts, Medicaid/other assistance, likely reducing local harm-reduction services and access to care.
Restricting funding may push supervised injection programs underground or out of jurisdiction, reducing oversight and potentially increasing public-health risks (e.g., unsafe injections, overdose) for vulnerable populations.
Conditioning federal funding on alleged violations shifts legal and administrative burdens to states and localities to enforce compliance or defend programs in court, raising costs and complexity for subnational governments.
Based on analysis of 2 sections of legislative text.
Denies federal funds to any state, local, Tribal, or private entity that operates or controls an injection center in violation of 21 U.S.C. § 856.
Official title: To prohibit Federal funds for any State, local, Tribal, or private entity that operates or controls an injection center in violation of section 416 of the Controlled Substances Act (21 U.S.C. 856; commonly referred to as the "Crack House Statute").
Introduced January 3, 2025 by Nicole Malliotakis · Last progress January 3, 2025
Prohibits the use of any federal funds for states, localities, tribes, or private entities that operate or control drug injection sites that violate federal law (21 U.S.C. § 856). The bill conditions federal financial assistance by applying the criminal, civil, and injunctive consequences tied to that statute through denial of federal funds to entities running unlawful injection centers.